This article provides a comprehensive analysis of the pivotal role played by the alarmone (p)ppGpp and the stringent response in the formation of bacterial persister cells, a major cause of...
The rapid emergence of novel and often multidrug-resistant bacterial species poses a significant threat to public health, necessitating robust frameworks for their virulence assessment.
This article provides a comprehensive guide for researchers and drug development professionals on the critical role of Sanger sequencing in validating Next-Generation Sequencing (NGS) findings.
The rapid discovery of novel bacterial species from clinical and environmental samples presents both opportunities and challenges for biomedical research and therapeutic development.
This article addresses the multifaceted challenges in evaluating the clinical relevance of new and drug-resistant bacteria, a critical task for researchers and drug development professionals.
The accurate identification of novel and clinically relevant bacteria is a cornerstone of modern microbiology, infectious disease control, and drug development.
Accurate detection of rare pathogens is critically hampered by complex sample processing hurdles, from low microbial biomass to inefficient nucleic acid extraction.
This article examines the critical challenge of misidentifying novel bacterial species using conventional phenotypic methods in clinical and research microbiology.
This article provides a comprehensive resource for researchers and drug development professionals on the application of mass spectrometry-based proteomics for characterizing unidentified bacterial pathogens.
This article explores the transformative role of broad-range PCR in detecting uncultivated and fastidious bacteria, a major challenge in clinical microbiology and microbial ecology.